Clinical significance of side population in ovarian cancer cells

作者: Shinji Hosonuma , Yoichi Kobayashi , Satoshi Kojo , Haruka Wada , Ken-ichiro Seino

DOI: 10.1007/S13577-010-0002-Z

关键词: Ovarian cancerPrimary tumorCancer researchClinical significanceBiologyPopulationOvaryCancer stem cellCancer cellSide population

摘要: Recently, accumulating evidence has suggested that tumors, including ovarian cancer, are composed of a heterogeneous cell population with small subset cancer stem cells (CSCs) sustain tumor formation and growth. The emergence drug resistance is one the most difficult problems in treatment which been explained recently by potential CSCs to have superior against anti-cancer drugs than conventional cells. In this study, we expanded line study examine whether phenomenon also observed clinical specimens total could analyze 28 samples out 60 obtained from patients. were subjected testing expression side (SP) as CSC marker, according presence SP (SP+) or absence (SP−), clinicopathological significances analyzed. Although there was no statistical significance, more SP+s recurrent cases well ascitic peritoneal dissemination primary ovary. There correlation between status FIGO staging. 19 those who be followed 6 months initial therapy, 8 recurrence death disease, all these SP+. On other hand, 11 disease-free survivors, 6 significant difference prognosis SP+ SP− (p = 0.017). limited, it revealed contained metastatic tumors risk factor cancer. Therefore, novel therapeutic strategy targeting improve

参考文章(17)
Xudong Huang, Yueyin Pan, Epithelial Ovarian Cancer Stem Cells—A Review International Journal of Clinical and Experimental Medicine. ,vol. 1, pp. 260- 266 ,(2008)
Sham S. Kakar, Miranda Y. Fong, The role of cancer stem cells and the side population in epithelial ovarian cancer. Histology and Histopathology. ,vol. 25, pp. 113- 120 ,(2010) , 10.14670/HH-25.113
Grant A. Challen, Melissa H. Little, A side order of stem cells: the SP phenotype. Stem Cells. ,vol. 24, pp. 3- 12 ,(2006) , 10.1634/STEMCELLS.2005-0116
Colleen Wu, Benjamin A. Alman, Side population cells in human cancers Cancer Letters. ,vol. 268, pp. 1- 9 ,(2008) , 10.1016/J.CANLET.2008.03.048
Kiyomi Takaishi, Yoshihiro Komohara, Hironori Tashiro, Hideyuki Ohtake, Takenobu Nakagawa, Hidetaka Katabuchi, Motohiro Takeya, Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation. Cancer Science. ,vol. 101, pp. 2128- 2136 ,(2010) , 10.1111/J.1349-7006.2010.01652.X
Nicholas Lambrou, Edward L. Trimble, Dose-intensive approaches to ovarian cancer. Current Oncology Reports. ,vol. 1, pp. 54- 58 ,(1999) , 10.1007/S11912-999-0010-X
Gerald G. Wulf, Rui-Yu Wang, Ingrid Kuehnle, Douglas Weidner, Frank Marini, Malcolm K. Brenner, Michael Andreeff, Margaret A. Goodell, A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood. ,vol. 98, pp. 1166- 1173 ,(2001) , 10.1182/BLOOD.V98.4.1166
Chenwei Li, David G. Heidt, Piero Dalerba, Charles F. Burant, Lanjing Zhang, Volkan Adsay, Max Wicha, Michael F. Clarke, Diane M. Simeone, Identification of Pancreatic Cancer Stem Cells Cancer Research. ,vol. 67, pp. 1030- 1037 ,(2007) , 10.1158/0008-5472.CAN-06-2030
M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, M. F. Clarke, Prospective identification of tumorigenic breast cancer cells Proceedings of the National Academy of Sciences of the United States of America. ,vol. 100, pp. 3983- 3988 ,(2003) , 10.1073/PNAS.0530291100
Lucia Ricci-Vitiani, Dario G. Lombardi, Emanuela Pilozzi, Mauro Biffoni, Matilde Todaro, Cesare Peschle, Ruggero De Maria, Identification and expansion of human colon-cancer-initiating cells Nature. ,vol. 445, pp. 111- 115 ,(2007) , 10.1038/NATURE05384